Dividends Calendar Earnings Calendar
EXEL

EXEL | Exelixis Inc

Healthcare sector

Exelixis Inc

EXEL Upgrades / Downgrades

Date Action Broker / Analyst Change Price Target
Mar 9, 2023InitiatedWells FargoOverweight $23
Oct 18, 2022InitiatedJMP SecuritiesMkt Outperform $26
Jun 24, 2022InitiatedBMO Capital MarketsOutperform $28
Nov 19, 2021InitiatedPiper SandlerOverweight $34
Nov 3, 2021ResumedJefferiesBuy $28
Oct 7, 2021InitiatedJefferiesBuy $28
Aug 6, 2021ReiteratedH.C. WainwrightBuy $64
Jun 15, 2021InitiatedH.C. WainwrightBuy $47
May 18, 2021ResumedGoldmanSell $23
Mar 31, 2021InitiatedCredit SuisseOutperform $30
Mar 12, 2021InitiatedWolfe ResearchOutperform $35
Mar 4, 2020InitiatedBarclaysOverweight $26
Jan 13, 2020InitiatedSunTrustBuy $31
Nov 13, 2019InitiatedBofA/MerrillBuy $22
Mar 18, 2019UpgradeMorgan StanleyUnderweight → Equal-Weight


Jump to (Finance sites)

Google   
         

Research 


Investor page

ir.exelixis.com

If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


Consensus
BUY 83
HOLD 17
SELL 0

Their Official Profiles 

WikipediaTwitterLinkedIn

Support this project

If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
More features coming soon :)

Social Media 




Recommended Books

The Intelligent Investor
Buy on Amazon

Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.

The best book on investing ever written.
-- Warren Buffet